Episode 56: Cheaper insulin, the next Juul, and diagnosing disease with sound
What if pharma just charged less for drugs? Can speaking three syllables reveal whether you're depressed? And why is Snoop Dogg selling erectile dysfunction pills on TV?
4 Apr 201928min
Episode 55: The fate of Bristol-Myers-Celgene, the tragedy of SIDS, and health tech's challenges
Why can't investors think for themselves? How do parents cope with inexplicable tragedy? And is tech prepared for the toughest parts of health care?
28 Mar 201926min
Episode 54: Another big Alzheimer’s failure, postpartum progress, and Long Island shores
Should Alzheimer's researchers just give up on amyloid plaques? What will a new drug mean for new moms with postpartum depression? And which coastal region of Long Island is superior?
21 Mar 201931min
Episode 53: How startups stop, the new FDA boss, and Theranos on the big screen
Who deserves credit for a new gene therapy? How do you push stop on a startup? And what does MC Hammer have to do with Theranos?
14 Mar 201931min
Episode 52: Every conceivable angle of Scott Gottlieb's FDA resignation
Why is Scott Gottlieb quitting the FDA? Who will replace him? And what's the proper elastane content of a skinny jean?
7 Mar 201928min
Episode 51: CEOs at the Senate, merger mania, and sleuthing startups
Is this the age of the big biotech buyout? Is cold brew a business expense? And how do you pronounce "Gonzalez"?
28 Feb 201926min
Episode 50: A big scoop on opioid marketing
What did an opioid patriarch say under oath? Why did everyone want to know so badly? And how might it shape the conversation around the opioid crisis?
22 Feb 201913min
Episode 49: Painkiller racketeering, the limits of genetic tests, and pharma's day on the Hill
Is pharma about to have its Big Tobacco moment? Are we overestimating human genetics? And can sales reps rap? We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech ...
21 Feb 201923min
